Age effect on bone mineral density changes in breast cancer patients receiving anastrozole: results from the ARBI prospective clinical trial

por Markopoulos, Christos, Tzoracoleftherakis, Evagelos, Koukouras, Dimitrios, Venizelos, Basileios, Zobolas, Vasilios, Misitzis, John, Xepapadakis, Grigorios, Gogas, Helen
Publicado 2012

Extended adjuvant hormonal therapy with exemestane has no detrimental effect on the lipid profile of postmenopausal breast cancer patients: final results of the ATENA lipid substud...

por Markopoulos, Christos, Dafni, Urania, Misitzis, John, Zobolas, Vasilios, Tzoracoleftherakis, Evagelos, Koukouras, Dimitrios, Xepapadakis, Grigorios, Papadiamantis, John, Venizelos, Basileios, Antonopoulou, Zoh, Gogas, Helen
Publicado 2009

Management of anastrozole-induced bone loss in breast cancer patients with oral risedronate: results from the ARBI prospective clinical trial

por Markopoulos, Christos, Tzoracoleftherakis, Evagelos, Polychronis, Athanassios, Venizelos, Basileios, Dafni, Urania, Xepapadakis, Grigorios, Papadiamantis, John, Zobolas, Vasilios, Misitzis, John, Kalogerakos, Kyriakos, Sarantopoulou, Angeliki, Siasos, Nikolaos, Koukouras, Dimitrios, Antonopoulou, Zoh, Lazarou, Spyros, Gogas, Helen
Publicado 2010